Cargando…

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expression profiling. A recurrent ch11q24.3 gain is observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Priebe, Valdemar, Sartori, Giulio, Napoli, Sara, Chung, Elaine Yee Lin, Cascione, Luciano, Kwee, Ivo, Arribas, Alberto Jesus, Mensah, Afua Adjeiwaa, Rinaldi, Andrea, Ponzoni, Maurilio, Zucca, Emanuele, Rossi, Davide, Efremov, Dimitar, Lenz, Georg, Thome, Margot, Bertoni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409072/ https://www.ncbi.nlm.nih.gov/pubmed/32679859 http://dx.doi.org/10.3390/cancers12071912

Ejemplares similares

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Sartori, Giulio, et al.
Publicado: (2021)

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014)

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
por: Tarantelli, Chiara, et al.
Publicado: (2018)

Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
por: Napoli, Sara, et al.
Publicado: (2021)

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2022)

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
por: Mensah, Afua A., et al.
Publicado: (2018)

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
por: Arribas, Alberto J., et al.
Publicado: (2022)

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
por: Spriano, Filippo, et al.
Publicado: (2022)

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
por: Gaudio, Eugenio, et al.
Publicado: (2020)

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type
por: Tarantelli, Chiara, et al.
Publicado: (2021)

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax
por: Tarantelli, Chiara, et al.
Publicado: (2019)

Correction to: cuRnet: an R package for graph traversing on GPU
por: Bonnici, Vincenzo, et al.
Publicado: (2018)

cuRnet: an R package for graph traversing on GPU
por: Bonnici, Vincenzo, et al.
Publicado: (2018)

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
por: Efremov, Dimitar G., et al.
Publicado: (2020)

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
por: Cascione, Luciano, et al.
Publicado: (2019)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
por: Guidetti, Francesca, et al.
Publicado: (2023)

Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors
por: Unzue, Andrea, et al.
Publicado: (2020)

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
por: Efremov, Dimitar G., et al.
Publicado: (2012)

Discovering Subgroups of Patients from DNA Copy Number Data Using NMF on Compacted Matrices
por: de Campos, Cassio P., et al.
Publicado: (2013)

Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation
por: Munz, Nicolas, et al.
Publicado: (2021)

Reduction of Prep1 Levels Affects Differentiation of Normal and Malignant B Cells and Accelerates Myc Driven Lymphomagenesis
por: Iotti, Giorgio, et al.
Publicado: (2012)

Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
por: Virgilio, Tommaso, et al.
Publicado: (2022)

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models
por: Hicks, Stuart W., et al.
Publicado: (2019)

HMGA1-pseudogene7 transgenic mice develop B cell lymphomas
por: De Martino, Marco, et al.
Publicado: (2020)

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
por: Paduano, Francesco, et al.
Publicado: (2018)

Publisher Correction: HMGA1-pseudogene7 transgenic mice develop B cell lymphomas
por: De Martino, Marco, et al.
Publicado: (2021)

Marginal zone lymphoma: Diagnostic challenges among different entities
por: Bongiovanni, Lucia, et al.
Publicado: (2018)

Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance
por: Dal-Bo, Michele, et al.
Publicado: (2009)

Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
por: Restelli, Valentina, et al.
Publicado: (2015)

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
por: González-Rincón, Julia, et al.
Publicado: (2019)

The Two Membrane Isoforms of Human IgE Assemble into Functionally Distinct B Cell Antigen Receptors
por: Batista, Facundo D., et al.
Publicado: (1996)

Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq
por: Giannuzzi, Diana, et al.
Publicado: (2019)

Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
por: Albertini, Veronica, et al.
Publicado: (2006)

Selective Preservation of Bone Marrow Mature Recirculating but Not Marginal Zone B Cells in Murine Models of Chronic Inflammation
por: Traggiai, Elisabetta, et al.
Publicado: (2010)

Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces
por: Sangaletti, Sabina, et al.
Publicado: (2020)

Bayesian DNA copy number analysis
por: Rancoita, Paola MV, et al.
Publicado: (2009)

An integrated Bayesian analysis of LOH and copy number data
por: Rancoita, Paola MV, et al.
Publicado: (2010)

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia
por: Bulian, Pietro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rjd6pnobthj57h0dddqqvp3f2f